
ML Melamed MD
@melamedmichal
Nephrologist and Epidemiologist at the Albert Einstein College of Medicine/ Montefiore Medical Center. Mother of 2 teens. Tweets are my own/ not medical advice.
ID: 1191863684072714246
05-11-2019 23:43:52
301 Tweet
655 Followers
716 Following

ML Melamed MD NYCTrainKUHR MonteNephrology Montefiore Pediatrics Kim Reidy Barbara T. Murphy Mount Sinai Div. of Nephrology Columbia Pediatrics We enjoyed Happy Hour get-together at Bryant Park Café Bryant Park Grill Bryant Park, outside the work setting. It was so much fun to see team members/trainees of this amazing training program!! Albert Einstein College of Medicine - Official Icahn School of Medicine at Mount Sinai Columbia Medicine

Our EinsteinMontefioreICTR has been awarded two NCATS NIH grants to support the education and training of clinical and translational researchers Albert Einstein College of Medicine - Official Montefiore Health System einsteinmed.edu/news/11045/mon…

Last Friday, trainees from @DGPNorthwestern and Chicago KUH FORWARD came together to share their stories and paths in STEMM with our #SciHigh scholars during our Trainee Panel Discussion. We are grateful for their time and willingness to support the next generation of scientists.🚀🔬





Excited to welcome ML Melamed MD to NYU Nephrology —looking forward to her bringing her science here and building great programs together !

ICYMI: Primary Care Medicine's Marina Kurian, MD & Rachel Lustgarten spoke with Director of NYU Langone Health Chronic Kidney Disease Center, ML Melamed MD LIVE Tues 3/12 from 8:30-9amET. We learned about risk factors, diagnosis, impact of #alcohol on kidneys & living w/ one kidney. #KidneyMonth

The 2024 NYCTrainKUHR Retreat, held at Albert Einstein College of Medicine - Official in NY, featured engaging presentations on career paths, negotiation, maintaining work-life balance, lively panel discussions, and social activities. A sincere appreciation to all the trainees, preceptors, and speakers involved!








FLOW Trial: Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular (CV) causes in patients with type 2 diabetes (T2D) and CKD ca. 2024 from NEJM Peter Rossing Vlado Perkovic Katherine Tuttle Christoph Wanner George Bakris george bakris




